What does APOTHEEK BUFAR do?

APOTHEEK BUFAR is a pharmacy in Zoutleeuw. Public Limited, started on 1 October 1986, 1 establishment.

What is the address of APOTHEEK BUFAR?

The registered office of APOTHEEK BUFAR is located at Groenstraat 13, 3440 Zoutleeuw.

Is APOTHEEK BUFAR still active?

Yes. According to the CBE (30 October 2026) APOTHEEK BUFAR is active, legal situation “Normale toestand”, started on 1 October 1986.

Is APOTHEEK BUFAR registered on Peppol?

Yes, APOTHEEK BUFAR is registered on the Peppol network with ID 0208:0429561035.

What is the enterprise number of APOTHEEK BUFAR?

The enterprise number of APOTHEEK BUFAR is BE0429561035.

When was APOTHEEK BUFAR founded?

APOTHEEK BUFAR was founded on 1 October 1986.

Who are the directors of APOTHEEK BUFAR?

According to the 2025 annual accounts, the directors of APOTHEEK BUFAR are: Peter Spiritus, Ingrid Catfolis.

Is APOTHEEK BUFAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 1986; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK BUFAR make in 2025?

APOTHEEK BUFAR posted a profit after taxes of € 137,941 in financial year 2025.

What is the revenue of APOTHEEK BUFAR?

As a small company, APOTHEEK BUFAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 290,890.

How many employees does APOTHEEK BUFAR have?

According to the 2025 annual accounts, APOTHEEK BUFAR has 0 full-time equivalents (FTE).

Does APOTHEEK BUFAR have a website?

Yes, APOTHEEK BUFAR has a website at apotheekspiritus.be.

APOTHEEK BUFAR (Public Limited) - Zoutleeuw

Dossier APOTHEEK BUFAR, printed on 30 October 2026 from databakkes.be/en/0429561035/apotheek-bufar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK BUFAR from Zoutleeuw, company number BE0429561035, closed financial year 2025 with a result of € 137,941 after tax. For that financial year APOTHEEK BUFAR recorded a gross margin of € 290,890 and equity of € 571,190. Compared with financial year 2024, the result moved from € 144,803 to € 137,941. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Healthy

€ 571,190

▼ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 137,941

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 187,295

▼ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 332,427 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1,995

▼ 24% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 51,614

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 285,351

▼ 17% vs 2024

€ 59,451 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 104,017

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,763

▲ 29% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 264,645 Gross margin 2022: € 264,645 First fiscal year in the series	€ 281,986 Gross margin 2023: € 281,986 ▲ 7% vs 2022 (€ 264,645) Favourable step	€ 305,612 Gross margin 2024: € 305,612 ▲ 8% vs 2023 (€ 281,986) Favourable step	€ 290,890 Gross margin 2025: € 290,890 ▼ 5% vs 2024 (€ 305,612) Unfavourable step	▼ 5%
Profit after taxes	€ 107,466 Profit after taxes 2022: € 107,466 First fiscal year in the series	€ 106,886 Profit after taxes 2023: € 106,886 ▼ 1% vs 2022 (€ 107,466) Unfavourable step	€ 144,803 Profit after taxes 2024: € 144,803 ▲ 35% vs 2023 (€ 106,886) Favourable step	€ 137,941 Profit after taxes 2025: € 137,941 ▼ 5% vs 2024 (€ 144,803) Unfavourable step	▼ 5%
Equity	€ 713,049 Equity 2022: € 713,049 First fiscal year in the series	€ 717,458 Equity 2023: € 717,458 ▲ 1% vs 2022 (€ 713,049) Favourable step	€ 765,676 Equity 2024: € 765,676 ▲ 7% vs 2023 (€ 717,458) Favourable step	€ 571,190 Equity 2025: € 571,190 ▼ 25% vs 2024 (€ 765,676) Unfavourable step	▼ 25%
Total debts	€ 612,460 Total debts 2022: € 612,460 First fiscal year in the series	€ 554,285 Total debts 2023: € 554,285 ▼ 9% vs 2022 (€ 612,460) Favourable step	€ 448,350 Total debts 2024: € 448,350 ▼ 19% vs 2023 (€ 554,285) Favourable step	€ 422,509 Total debts 2025: € 422,509 ▼ 6% vs 2024 (€ 448,350) Favourable step	▼ 6%
Cash	€ 405,756 Cash 2022: € 405,756 First fiscal year in the series	€ 306,726 Cash 2023: € 306,726 ▼ 24% vs 2022 (€ 405,756) Unfavourable step	€ 334,401 Cash 2024: € 334,401 ▲ 9% vs 2023 (€ 306,726) Favourable step	€ 187,295 Cash 2025: € 187,295 ▼ 44% vs 2024 (€ 334,401) Unfavourable step	▼ 44%
Land & buildings	€ 566,958 Land & buildings 2022: € 566,958 First fiscal year in the series	€ 505,360 Land & buildings 2023: € 505,360 ▼ 11% vs 2022 (€ 566,958) Unchanged	€ 460,150 Land & buildings 2024: € 460,150 ▼ 9% vs 2023 (€ 505,360) Unchanged	€ 423,930 Land & buildings 2025: € 423,930 ▼ 8% vs 2024 (€ 460,150) Unchanged	▼ 8%
Retained profit	€ 651,049 Retained profit 2022: € 651,049 First fiscal year in the series	€ 655,458 Retained profit 2023: € 655,458 ▲ 1% vs 2022 (€ 651,049) Favourable step	€ 703,676 Retained profit 2024: € 703,676 ▲ 7% vs 2023 (€ 655,458) Favourable step	€ 509,190 Retained profit 2025: € 509,190 ▼ 28% vs 2024 (€ 703,676) Unfavourable step	▼ 28%
Dividend	€ 3,200 Dividend 2022: € 3,200 First fiscal year in the series	€ 102,477 Dividend 2023: € 102,477 ▲ € 99,277 vs 2022 (€ 3,200) Unchanged	€ 96,586 Dividend 2024: € 96,586 ▼ 6% vs 2023 (€ 102,477) Unchanged	€ 332,427 Dividend 2025: € 332,427 ▲ 244% vs 2024 (€ 96,586) Unchanged	▲ 244%
Bank debt	€ 492,836 Bank debt 2022: € 492,836 First fiscal year in the series	€ 405,849 Bank debt 2023: € 405,849 ▼ 18% vs 2022 (€ 492,836) Favourable step	€ 342,336 Bank debt 2024: € 342,336 ▼ 16% vs 2023 (€ 405,849) Favourable step	€ 285,351 Bank debt 2025: € 285,351 ▼ 17% vs 2024 (€ 342,336) Favourable step	▼ 17%
Balance sheet total	€ 1,325,509 Balance sheet total 2022: € 1,325,509 First fiscal year in the series	€ 1,271,743 Balance sheet total 2023: € 1,271,743 ▼ 4% vs 2022 (€ 1,325,509) Unchanged	€ 1,214,026 Balance sheet total 2024: € 1,214,026 ▼ 5% vs 2023 (€ 1,271,743) Unchanged	€ 993,699 Balance sheet total 2025: € 993,699 ▼ 18% vs 2024 (€ 1,214,026) Unchanged	▼ 18%
Employees (FTE)	-	0.1 Employees (FTE) 2023: 0.1 First fiscal year in the series	0 Employees (FTE) 2024: 0 ▼ 0.1 vs 2023 (0.1) Unchanged	0 Employees (FTE) 2025: 0 Unchanged (0) Unchanged

Key figures of APOTHEEK BUFAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK BUFAR?

What happened at APOTHEEK BUFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 137,941 (▼ 5% vs 2024). Source: NBB ↗
2026 Peter Spiritus stepped down as director. NBB
2026 Ingrid Catfolis stepped down as director. NBB
2020 Peter Spiritus became a director. NBB
2020 Ingrid Catfolis became a director. NBB
Nov 4, 1986 New establishment in Zoutleeuw. KBO
Oct 1, 1986 Start of the company according to the CBE. KBO

In short

From € 107,466 profit in 2022 to € 137,941 profit in 2025.

Paid € 218,081 in corporate taxes since 2022.

Best year ever: 2024, with € 144,803 profit.

Paid out € 534,690 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Peter Spiritus

Managing director

since 2020 · until 2026

Ingrid Catfolis

Managing director

Also active at: LINTERPHARMA

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Groenstraat 13

3440 Zoutleeuw

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

WIELERTOERISTEN CLUB BAKHUIS

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekspiritus.be

About

Technologies

Alpine.jsApacheBunny CDNFont AwesomeGoogle FontsreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-02 - Amazon.com, Inc., US

DNS

AWS Route 53

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Client portal Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0429.561.035

VAT number

BE 0429.561.035

Registered office

Groenstraat 13, 3440 Zoutleeuw

Names & denominations

APOTHEEK BUFAR

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

1 October 1986

Peppol

Active · Active since 10 Dec 2025

Contact

apotheekspiritus.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗